Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
832.00    12.00 (1.46%)
Bid:
829.00
Ask:
832.00
Spread: 3.00 (0.362%)
Market Cap: £785.78m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

12 Jan 2017 07:00

RNS Number : 9517T
Polar Capital Holdings PLC
12 January 2017
 

12 January 2017

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the boutique investment management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 December 2016 its AUM were £8.4bn compared to £7.3bn at the end of March 2016.

 

AUM movement in

nine months to

31 December 2016

USD

GBP

Long only

Funds

Alternative funds

Total

Long only

funds

Alternative funds

Total

AUM at

31 March 2016

$9,378m

$1,054m

$10,432m

£6,531m

£734m

£7,265m

Net subscriptions

/ (redemptions)

$(722)m

$56m

$(666)m

£(493)m

£45m

£(448)m

Market movement

and performance

$653m

$(45)m

$608m

£1,506m

£84m

£1,590m

Total AUM at

31 December 2016

$9,309m

$1,065m

$10,374m

£7,544m

£863m

£8,407m

 

Comment

 

In mid-December we released our interim results and at the time provided guidance that the US election result in November had triggered a noticeable change in flows into our funds. December has continued in the same vein that November finished and it is pleasing to report that more than £100m of net inflows were received in the month into our products, giving a total net flow for the quarter of over £300m.

 

On a less positive note the performance fees earned in the year were below the level of last year although this was the 16th consecutive year that such fees have been earned.

 

Whilst this was not our best year in terms of overall investment performance, our medium and longer term performance numbers on our UCITS products remain extremely strong, as shown in the table below. Thirteen of our eighteen Lipper rated UCITS funds are top quartile since launch, eight of which are top decile, whilst the other five funds are second quartile (as at 31 December 2016).

 

1 year

3 years

5 years

Since

inception

1st quartile

7 funds

8 funds

6 funds

13 funds

2nd quartile

5 funds

2 funds

2 funds

5 funds

3rd quartile

6 funds

3 funds

1 fund

0 funds

4th quartile

0 funds

1 fund

1 fund

0 funds

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first nine months of the Group's financial year.

 

Performance fees

net of staff allocations

Nine months to

31 Dec 15

Year to

31 Mar 16

(year-end)

Nine months to

31 Dec 16

Received

£3.0m

£3.0m

£1.1m

Accrued but not yet earned in funds with year ends on or before the financial year end

-

-

-

Total net performance fees

£3.0m

£3.0m

£1.1m

 

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Kit Stephenson

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDEAXFFFFDXEFF
Date   Source Headline
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding
13th Oct 20227:00 amRNSAuM Update
29th Sep 202210:33 amRNSHolding(s) in Company
7th Sep 20224:18 pmRNSResult of AGM
31st Aug 20222:03 pmRNSForm 8.3 - Diurnal Group PLC
26th Aug 20229:20 amRNSHolding(s) in Company
1st Aug 20227:00 amRNSBlock listing Interim Review
21st Jul 202212:14 pmRNSDirector/PDMR Shareholding - Replacement
20th Jul 202210:57 amRNSDirector/PDMR Shareholding
20th Jul 202210:26 amRNSDirector/PDMR Shareholding
14th Jul 20224:11 pmRNSHolding(s) in Company
14th Jul 20227:00 amRNSAuM Update
13th Jul 20223:25 pmRNSForm 8.3 - Serica Energy PLC
13th Jul 202210:23 amRNSDirector/PDMR Shareholding
6th Jul 20225:50 pmRNSDirector/PDMR Shareholding
29th Jun 20221:10 pmRNSHolding(s) in Company
27th Jun 20227:00 amRNSGroup Audited Results for year ended 31 March 2022
21st Jun 20227:00 amRNSInvestor Presentation covering Preliminary Results
15th Jun 202210:59 amRNSHolding(s) in Company
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202210:01 amRNSIssue of Equity
26th May 20227:00 amRNSNotice of Results
16th May 20224:26 pmRNSHolding(s) in Company
6th May 20224:55 pmRNSDirector/PDMR Shareholding
4th May 202212:15 pmRNSDirector/PDMR Shareholding
28th Apr 20222:38 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSAuM Update
12th Apr 20227:00 amRNSFund Terminations
11th Apr 20225:03 pmRNSHolding(s) in Company
30th Mar 20229:18 amRNSDirector/PDMR Shareholding
25th Feb 20221:03 pmRNSDirector/PDMR Shareholding
23rd Feb 20223:47 pmRNSForm 8.3 - Clipper Logistics plc
23rd Feb 20223:44 pmRNSForm 8.3 - Clipper Logistics plc
23rd Feb 20221:27 pmRNSDirector/PDMR Shareholding
22nd Feb 20221:12 pmRNSDirector/PDMR Shareholding
1st Feb 20222:53 pmRNSDirector/PDMR Shareholding
1st Feb 20227:00 amRNSBlock listing Interim Review
25th Jan 20225:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.